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Abstract
The confounding consequences of Helicobacter bilis infection in experimental mice populations are well recognized, but the
role of this bacterium in human diseases is less known. Limited data are available on virulence determinants of this species. In
Helicobacter pylori, c-glutamyltranspeptidase (cGT) contributes to the colonization of the gastric mucosa and to the
pathogenesis of peptic ulcer. The role of cGT in H. bilis infections remains unknown. The annotated genome sequence of H.
bilis revealed two putative ggt genes and our aim was to characterize these H. bilis cGT paralogues. We performed a
phylogenetic analysis to understand the evolution of Helicobacter cGTs and to predict functional activities of these two genes.
In addition, both copies of H. bilis cGTs were expressed as recombinant proteins and their biochemical characteristics were
analysed. Functional complementation of Esherichia coli deficient in cGT activity and deletion of cGT in H. biliswere performed.
Finally, the inhibitory effect of T-cell and gastric cell proliferation by H. bilis cGT was assessed. Our results indicated that one
gene is responsible for cGT activity, while the other showed no cGT activity due to lack of autoprocessing. Although both H.
bilis and H. pylori cGTs exhibited a similar affinity to L-Glutamine and c-Glutamyl-p-nitroanilide, the H. bilis cGTwas significantly
less active. Nevertheless, H. bilis cGT inhibited T-cell proliferation at a similar level to that observed for H. pylori. Finally, we
showed a similar suppressive influence of both H. bilis and H. pylori cGTs on AGS cell proliferation mediated by an apoptosis-
independent mechanism. Our data suggest a conserved function of cGT in the Helicobacter genus. Since cGT is present only in
a few enterohepatic Helicobacter species, its expression appears not to be essential for colonization of the lower
gastrointestinal tract, but it could provide metabolic advantages in colonization capability of different niches.
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Introduction
c-Glutamyltranspeptidase (cGT) is a threonine N-terminal
nucleophile (Ntn) hydrolase that catalyses the transpeptidation
and hydrolysis of the c-glutamyl group of glutathione and related
compounds [1]. cGT is widely distributed in living organisms and
is highly conserved, with mammalian and bacterial homologues
often sharing more than 25% of sequence identity [2]. From the
,1000 of whole genome sequenced bacterial species available in
MEROPS databases (http://merops.sanger.ac.uk [3]), 540 (,200
genera) possess cGT-like proteins belonging to protease family
T03. Moreover, several bacterial species carry multiple copies of
genes annotated as cGT, but the majority of these genes lack
functional verification.
cGT is found in all gastric Helicobacter species. However, among
the 20 validly published enterohepaticHelicobacter species (EHS), only
H. aurati, H. bilis, H. canis, H. muridarum and H. trogontum express this
enzyme [4]. In H. pylori, cGT represents an important virulence
factor, playing a role in colonization [5,6] and pathogenesis [7–10].
It is constitutively expressed in vivo and in vitro [11] and enables the
bacterial cells to use extracellular glutamine and glutathione as a
source of glutamate [9,12]. Purified Hp-cGT was shown to be
involved in upregulation of growth factors in MKN-28 gastric cells
[7], to induce apoptosis in AGS cells [10], to inhibit T-cell
proliferation [9] and to contribute to H. pylori–mediated H2O2
generation [8]. By contrast, the biochemical properties of EHS cGT
and its role in the colonization of the gut and in the pathogenesis of
gastrointestinal and hepatobiliary diseases are completely unknown.
EHS is a phenotypically and genotypically heterogeneous phy-
logroup within the Helicobacter genus [4], including species usually
colonizing the intestinal tract and/or the liver of mammals and birds.
Although EHS could be considered part of the normal microbiota of
rodents, some species cause diseases in these animals [13]. In
particular, H bilis, an endemic EHS in most experimental mouse
colonies, induces disease in susceptible animals andmay substantially
confound interpretations of some research studies [14]. Natural H.
bilis infection in inbred [15] or outbred mice [16] has been associated
with multifocal hepatitis. Moreover, H. bilis has been used
experimentally to induce inflammatory bowel disease (IBD) in
mdr2/2 and IL-102/2 knock-out mice [16], typhlocolitis in the
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C3H/HeN mice strain [17] and cholesterol gallstone formation in
C57L mice [18]. H. bilis is able to infect and cause diseases in
different animal hosts, showing one of the broadest host spectrums in
the Helicobacter genus [19]. It was isolated from the aborted fetus of
sheep and pig [19] and from chronic hepatobiliary diseases in
hamsters [20]. H. bilis has been also isolated from human patients
with chronic diarrhoea [21] and pyoderma gangrenosum-like ulcers
[22]. In addition, several studies have reported an association of this
species with chronic liver diseases [23,24] or biliary tract and
gallbladder cancers [25,26] in human, using either PCR or
serological tests. Limited data are available on virulence determi-
nants of H. bilis [27–29], and no studies to date have described the
biochemical and biological proprieties of H. bilis cGT (Hb-cGT).
In contrast to observations in gastric Helicobacter spp., the
genome sequence of H. bilis ATCC 43879 revealed the presence of
two ggt copies. In this study, we used a phylogenetic and a
functional approach to analyse both H. bilis cGT paralogues.
Although both genes were phylogenetically related to other
Helicobacter cGTs, analysis of the recombinant proteins, western
blot using specific antibodies, complementation of E. coli Dggt and
mutation in H. bilis clearly showed that only one gene was
responsible for H. bilis cGT activity. The cGT of H. bilis exhibited
a similar affinity as H. pylori to c-Glutamyl-p-nitroanilide and to L-
Glutamine; however, it was significantly less active. Nevertheless,
H. bilis cGT inhibited T-cell and gastric cell proliferation at a
similar level to that observed for H. pylori cGT. The inhibition
observed was mediated by an apoptosis-independent mechanism
and suggested a conserved function of cGT in Helicobacter genus.
Results
Sequence analysis revealed marked differences between
two cGT paralogues of H. bilis ATCC 43879
The ggt paralogues HRAG_01341 and HRAG_01828 of the
human-associated H. bilis strain ATCC 43879 genome (NCBI
ACDN0000000), were named bgh1 (H. bilis ggt homologue 1) and
bgh2 (H. bilis ggt homologue 2), respectively. Nucleotide and amino
acid similarity between the two H. bilis cGT paralogues, and
between each homologue and H. pylori cGT (Hp-cGT; HP1118)
were analysed by pairwise global alignment. The two H. bilis cGT
paralogues showed 65.8% and 62.0% of nucleotide and amino
acid identity, respectively. Moreover, in comparison with Hp-
cGT, Bgh2 showed 65.2% of amino acid identity, while Bgh1
showed 53.4%. To detect amino acid positions potentially
involved in functional change, conserved sites of both Bgh1 and
Bgh2 genes were evaluated on the basis of cGT structural data
available for H. pylori [30,31] and E. coli [32]. A multi-alignment
including all Helicobacter cGT sequences, other bacterial cGTs and
class IV cephalosporin acylase (CA) of Pseudomonas sp. strain SE82,
was constructed (Figure 1). In Bgh2, all the functional sites
described for H. pylori are conserved. In Bgh1, by contrast, amino
acid substitutions in the 20 kDa subunit potentially involved in
functional change were observed. The substitutions were as
follows: Asp421Glu, Asp422Asn, Leu432Arg, Tyr433His,
Ser452Thr and Gly473Ser (Hp-cGT numeration).
To predict the localization of both H. bilis cGT paralogues, the
sequences were submitted to SignalP 3.0, using both Neural
networks and Hidden Markov Models (HMM) methods [33],
PSLpred (Hybrid Approach Based; [34]), PSORTb v3.0.2 [35]
and CELLO v2.5 [36]. These tools were unable to uniformly
predict the sub-cellular localization of both Bgh1 and Bgh2. To
verify the presence of other potential start codons, we analysed the
upstream region of both genes. We identified a second putative
start codon 54 bp upstream of the annotated methionine of Bgh2,
but no other potential start codons for Bgh1. Using the new
predicted start codon, all of the analysis strongly predicted Bgh2 as
a periplasmic protein, and SignalP detected the presence of sec
signal peptide sequence with a potential cleavage site between
positions 30 and 31 (VFA-AS). The same prediction was obtained
for all cGTs of Helicobacter spp. and C. jejuni. No twin-arginine
signal peptide cleavage site was detected in any cGTs of
Helicobacter spp. and C. jejuni.
Figure 1. Multi-alignment of amino acid sequences of different bacterial cGTs, Helicobacter bilis Bgh1 and Bgh2, and class IV
Cephalosporin Acylase (CA). Multi-alignment between residues 379 and 477 (Helicobacter pylori cGT numeration) is shown. Sequences of cGTs of
H. pylori (26695; HP1118), H. acinonychis (Sheeba; Hac_0598), H. bizzozeronii (CIII-1;HBZC1_08080), H. salomonis (O6A; EMBL FR821684), H. suis (HS1;
HSUHS1_0265), H. felis (ATCC 49179; Hfelis_06880), H. mustelae (12198; HMU08020), Esherichia coli (K12; Swiss-Prot P18956), Campylobacter jejuni (81–
176; CJJ81176_0067), Pseudomonas sp. (A14; Swiss-Prot P36267), Bacillus subtilis (168; Swiss-Prot P54422), Arcobacter nitrofigilis (DSM 7299;
Arnit_0203), Arcobacter butzleri (RM4018; Abu_0961), H. bilis (Bgh1=HRAG_01341; Bgh2=HRAG_01828) as well as class IV CA of Pseudomonas sp.
(SE82; Swiss-Prot P15557) are shown. Residues completely conserved among the sequences are indicated with a black background. The catalytic dyad
is highlighted with a red box, and the conserved motif GXXGGXXI is enclosed in a black box. The Lid loop consists of the residues G428 to G438 of H.
pylori cGT and is indicated in grey. Residues involved in the substrate recognition and the catalytic centre are highlighted in grey. Amino acid
substitutions in Bgh1 potentially involved in functional change are indicated by arrows below the sequences.
doi:10.1371/journal.pone.0030543.g001
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Phylogenetic analysis of Helicobacter cGTs
Phylogenetic relationships among epsilon proteobacteria and
other bacterial cGTs and Pseudomonas spp. CA were analysed
(Figure 2). The Minimum Evolution tree based on amino acid
sequence alignment showed that both H. bilis cGT paralogues
cluster with Helicobacter and C. jejuni cGTs, forming, however, two
distinct branches: Bgh2 and C. jejuni cGT belonged to a single
clade, while Bgh1 formed a separate branch.
To examine the phylogenetic relationships among Helicobacter
cGTs in more detail and to identify other Helicobacter species
potentially carrying multiple cGT sequences, consensus degener-
ate hybrid oligonucleotide primers were designed on the basis of
highly conserved amino acid motifs (Table 1). A fragment of about
1300 bp, corresponding to an almost complete ggt sequence, was
successfully amplified from H. canis, and two fragments, corre-
sponding to an almost complete sequence of two distinct ggt copies,
were amplified from H. trogontum and H. bilis genomospecies FL56.
From H. aurati and H. muridarum, amplification of only the N-
terminal part of a single ggt copy was possible. An unrooted
Minimum Evolution tree was built on the basis of an almost
complete amino acid sequence of the cGT pro-enzyme of
Helicobacter spp. and C. jejuni (Figure 3a). Phylogenetic analysis
showed that the two ggt copies amplified from H. trogontum and H.
bilis genomospecies FL56 corresponded to orthologues of bgh1 and
bgh2, whereas the sequences obtained from H. canis, H. aurati and
H. muridarum (Figure 3a,b) clustered with other Helicobacter ggt and
bgh2. In Figure 3, the phylogeny of the pro-enzyme was compared
with those of the single sub-units. The trees showed differences in
both the topology and the bootstrap supporting nodes, suggesting
different evolution of the two parts. The same results were
obtained comparing the maximum likelihood trees of the
nucleotide sequences (data not shown). Finally, to provide a
measure for the selective pressure that the gene pair bgh1 and bgh2
was subjected to, the ratio between non-synonymous/synonymous
substitution (Ka:Ks) was evaluated by sliding window analysis
(window size 50 bp) using SWAKK [37]. A Ka:Ks ratio smaller
than one was observed in all positions analysed. The average
Ka:Ks ratio was calculated to be 0.175, indicating that the genes
are under purifying selection. A similar Ka:Ks ratio was observed
also for the bgh1 and bgh2 pairs of H. trogontum and H. bilis
genomospecies FL56 (data not shown).
Frequency of bgh1 and bgh2 genes in H. bilis strains
To determine the frequency of bgh1 and bgh2 in H. bilis, 33 H.
bilis strains from our collection [38], including H. bilis type strain
ATCC 51630T, H. bilis ATCC 49314 and H. bilis ATCC 49320,
were subjected to a specific BclI RFLP-PCR for bgh1 and a specific
PCR for bgh2. All strains were positive for the presence of both
genes. Furthermore, bgh1 orthologues of H. bilis type strain ATCC
51630T and three canine strains [38] were sequenced and
uncorrected distance matrices were constructed on the basis of
both nucleotide and amino acid sequences. The overall nucleotide
sequence identity observed varied from 94.7% to 97.3%, while the
amino acid identity ranged from 97.5% to 100%.
Transcription of bgh1 and bgh2 by H. bilis CCUG 23435
The transcription of both bgh1 and bgh2 was evaluated in H. bilis
CCUG 23435 at different time points. Bacterial growth was
Figure 2. Unrooted tree based on complete amino acid sequences of different bacterial cGTs, Helicobacter bilis Bgh1 and Bgh2, and
Pseudomonas Cephalosporin Acylase (CA). The evolutionary history was inferred using the Minimum Evolution method and the evolutionary
distances were computed using the Dayhoff matrix-based method. Bar indicates amino acid substitutions per position. Numbers at the nodes
indicate support for the internal branches within the tree obtained by bootstrap analysis ($70%; percentages of 500 bootstraps).
doi:10.1371/journal.pone.0030543.g002
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monitored by measuring OD600 up to 24 h, corresponding
approximately to the end of the exponential phase. At 8, 12 and
24 h both genes were transcribed (data not shown).
Expression, purification and autoprocessing of
recombinant Bgh1 and Bgh2 proteins
To further analyse the biochemical characteristics of both H.
bilis cGT paralogues, we expressed recombinant His-tagged Bgh1
and Bgh2 proteins in E. coli. Bgh2 was expressed without the signal
peptide, while for Bgh1 the entire sequence was used. Recombi-
nant expression of Bgh2 resulted in a soluble protein that was
directly purified by Ni-affinity chromatography. By contrast, Bgh1
was expressed as an insoluble protein of ,70 KDa and was
purified after refolding. The purity of the proteins on SDS-PAGE
was .90% (Figure 4a). Bgh2 showed a catalytic activity for the
substrate analogue L-c-glutamyl-p-nitroanilide (gGpNA) and was
synthesized as a pro-form of ,60 KDa, which undergoes
autocatalytic processing to generate two subunits of ,40 and
,20 KDa (Figure 4a). By contrast, after solubilisation and
refolding, recombinant Bgh1 showed no significant maturation
after 24 h of incubation at 37uC and no activity for gGpNA
(Figure 4b). To estimate the secondary structure of Bgh1 and to
verify the absence of a random folding, a Circular Dichroism (CD)
spectrum of the recombinant protein was calculated. The
spectrum minimum calculated for recombinant Bgh1 was
206 nm, indicating the absence of random coil. The secondary
structure of Bgh1 was predicted by K2D3 [39] to contain 30.23%
of alfa helix and 16.82% of beta sheet. The CD spectrum for
Bgh1resulted similar to the spectrum predicted by K2D3 and to
those for proper folded proteins, e.g. lysozyme [40], indicating that
recombinant Bgh1 has a defined secondary structure (Figure S1).
Autoprocessing of Bgh1 and Bgh2 in H. bilis
In order to evaluate the maturation of both Bgh1 and Bgh2 in
H. bilis, antisera against both recombinant proteins were produced
in mice and western blot analysis on H. bilis whole lysate was
performed. The antisera showed high specificity for the corre-
sponding H. bilis cGT paralogue in ELISA test at 1:900 dilution
selected for the subsequent western blots (data not shown). The
western blot performed on H. bilis whole lysate using the antiserum
against Bgh1 clearly showed a single band without indication of
autoprocessing (Figure 5a). On the contrary, the western blot
Table 1. Oligonucleotides used in this study.
Oligonucleotides Sequence
ggtCODEHOPfw-b GATGAAGGCGGGAATGCTathgaygcngc (conserved a.a. IDAA)
ggtCODEHOPrw-k CAATTCTAATTTCATCAGGTAGCcaytgcatrtg (conserved a.a. HMQW)
ggtCODEHOPfw-g ATCCATATTATGGCTGAAGCTatgmgncargc (conserved a.a. MRQA)
ggtCODEHOPrw-g ACGCTTCTATCAGCATAAGCTtgnckcatngc (conserved a.a. MRQA)
ggt_seqCODEHOPfw-b GATGAAGGCGGGAATGCT
ggt_seqCODEHOPrw-k CAATTCTAATTTCATCAGGTAGC
ggt_seqCODEHOPfw-g ATCCATATTATGGCTGAAGC
ggt_seqCODEHOPrw-g ACGCTTCTATCAGCATAAGCT
1341fw AAGTCGCACCAAAGGCAGCTAGTC
1341rw ATCGCTTGCTGTCGCCCTATTTGTC
1828fw AAGGTGGGGATACACTCG
1828rw GGTGATTCTACCGCTTTTGC
1341fw-RFLP GCAAAAAGAAGGCGAGAGTG
1341rw-RFLP TGAAAGCGTGGAGATTCTAC
HRAG1341pBADKpnI AGCAGGTACCGCTATTATCATATCTAAAACCGCTAG
HRAG1341FwNdeI ACGCCATATGATGCTATTATCATATCTAAAACCGCTAG
HRAG1341RwHindIII CCCAAGCTTTTATATCTTCCTTCTAGGGTCTAATGTG
HRAG1828pBADKpnI AGCAGGTACCGACAGGGTTTTTAAGCGTGAGTG
HRAG1828FwNheI CTAGCTAGCATGACAGGGTTTTTAAGCGTGAG
HRAG1828RwHindIII CCCAAGCTTTTAAAACTCTTTTCTTGGATCATTTACTC
HRAG1828up5PstI ATTCTGCAGATGACAGGGTTTTTAAGCGTGAG
HRAG1828up3XbaI ATTCTAGAGTGATTACCCTCTTTGTGATTTATAGGTTGTCC
HRAG1828dw5KpnI ATGGTACCGCAAGTTATGGTGCGATAGCAGAGGTTGAAG
HRAG1828dw3EcoRI ATGAATTCTTAAAACTCTTTTCTTGGATCATTTACTC
U1catF2 ATTCTAGACGGCGGTGTTCCTTTCCAAG
U1catR ATGGTACCCGCCCTTTAGTTCCTAAAGGG
up1828 CGTCAGTTAAATTACTTGCAGCC
dw1828 CTTAAAAGGGGAGAGTTTATTTACCTG
CatR CCCTTATCGATTCAAGTGCATCATG
CatL TAGTGGTCGAAATACTCTTTTCGTG
doi:10.1371/journal.pone.0030543.t001
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carried out using antiserum against Bgh2 revealed the expression
of the pro-form and its corresponding two subunits (Figure 5b).
These results confirmed that both proteins are expressed in H. bilis
and that only Bgh2 undergoes autocatalytic processing.
Complementation of E. coli Dggt
To evaluate the capability of H. bilis cGT paralogues to
functionally complement an E. coli cGT-deficient strain, Bgh1 or
Bgh2 (carried on plasmid pMRg3 and pMRg5, respectively) were
introduced in E. coli CY128 [41]. E. coli DH5a grown in LB
overnight at 25uC was used as positive control in cGT assay. Only
Bgh2 was found to successfully complement E. coli CY128, while
Bgh1 was unable to restore cGT activity (data not shown). The
induction of pMRg3 in E. coli CY128 resulted in a clear inhibition
of growth. This finding was consistent with formation of inclusion
bodies, as a consequence of the overexpression of Bgh1. However,
when the protein was expressed overnight at a lower temperature
(15uC) with low amount of inducer (0.002% instead of 0.2%), there
was no inhibition of the growth rate of E. coli, suggesting a low
accumulation of insoluble proteins. The successful expression of
Bgh1 under improved conditions was confirmed by SDS-PAGE
(data not shown). Nevertheless, Bgh1 was not able to complement
E. coli Dggt, while Bgh2, expressed under the same conditions,
restored cGT activity in the mutant strain.
Construction of a H. bilis mutant deficient in cGT activity
To confirm that Bgh2 is responsible of the cGT activity in H.
bilis, a mutant of bgh2 was constructed in CCUG 23435 strain. The
bgh2 gene was disrupted by insertion of a chloramphenicol cassette
between positions 1182 and 1246, in order to delete the threonine-
threonine catalytic dyad. The successful insertion of the chor-
amphenicol resistance cassette and the deletion of bgh2 were
confirmed by PCR. RT-PCR and western blot analysis showed
the expression of bgh1 in both wild-type and mutant strains (data
not shown), indicating that the replacement of bgh2 had no effect
on the expression of the bgh1 paralogue gene. Since complemen-
tation approaches are currently unavailable for H. bilis, another
independent Dbgh2 mutant was used as a control for secondary
mutations. Neither of the H. bilis mutants were able to hydrolyse
the substrate analogue gGpNA. Moreover, in the supernatant of
H. bilis wild-type cGT activity was determined with a gGpNA
turnover of 0.48 mM/min at a concentration of 50 mg/mL of total
protein. No activity was detected in the supernatant of the mutant
strain MR9 (Figure S2). These results indicate that only bgh2
encodes a functional cGT in H. bilis CCUG 23435 (Hb-cGT).
The mutants grew normally in vitro, as described for H. pylori cGT-
deficient strains [9], indicating that cGT is not essential for
survival and growth of both H. pylori and H. bilis in vitro.
Figure 4. Purity and autoprocessing of recombinant Bgh1 and
Bgh2. (A) SDS-page of the purified proteins after gel filtration: Bgh1
(Lane 1) and fully autoprocessed Bgh2 (Lane 2); (B) time-line for
autoprocessing of Bgh1.
doi:10.1371/journal.pone.0030543.g004
Figure 3. Unrooted tree based on the amino acid sequences of: Helicobacter spp. cGTs, Campylobacter jejuni cGTs and Bgh1 and Bgh2
homologues of Helicobacter trogontum and Helicobacter bilis. The evolutionary history was inferred using the Minimum Evolution method, and
the evolutionary distances were computed using the Dayhoff matrix-based method. Bars indicate amino acid substitutions per position. Numbers at
the nodes indicate support for the internal branches within the tree obtained by bootstrap analysis ($70%; percentages of 500 bootstraps). (A)
Phylogeny of almost complete pro-enzyme sequences (447 AA). (B) Phylogeny of almost complete N-terminal cGT sequences (Heavy chain; 333 AA).
(C) Phylogeny of the almost complete C-terminal cGT sequences (Light chain; 190 AA).
doi:10.1371/journal.pone.0030543.g003
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Biochemical characterization of recombinant Bgh2 (Hb-
cGT) and comparison with H. pylori cGT (Hp-cGT)
The kinetic parameters of recombinant Bgh2 (Hb-cGT) were
measured. The initial experiments were performed at pH 8.0. The
KM was determined by titration of the gGpNA concentrations
between 1 and 1000 mM. The processed Hb-cGT had a KM of
7.761.2 mM and a kcat of 1.1260.03N10
2/sec. Compared with KM
and kcat values calculated for Hp-cGT (KM=9.861.5 mM and
kcat = 17.760.5N102/sec), the apparent KM value for Hb-cGT was
20% lower, while the kcat value was .10-fold reduced (Table 2).
The pH dependence of the Hb-cGT activity was analysed and
compared to Hp-cGT (Figure 6). The pH profile of Hp-cGT
activity was similar to reported data [30] (data not shown),
whereas the activity optimum of Hb-cGT was shifted to a more
acidic pH between 6.0 and 7.0. By contrast, the KM was increased
more than 2-fold at this pH range. Initial experiments for
comparing the substrate specificity of Hp-cGT and Hb-cGT for
glutathione, D-glutamine, L-glutamine and L-glutamic acid were
performed by a competition assay. A better binding affinity to the
active cGT and therefore a competitive inhibition of the gGpNA-
reaction would be expected for its native substrates. As previously
described [9,12], Hp-cGT substrate inhibition was observed for
both by glutathione and L-glutamine, whereas Hb-cGT was only
inhibited by L-glutamine (Figure S3).
Inhibition of human T-cell and AGS cell proliferation
To evaluate biological properties of recombinant Hb-cGT and
compare these with effects already observed for Hp-cGT, the
ability of Hb-cGT to inhibit human T-cell and AGS cell
proliferation was assessed. Recombinant Hb-cGT efficiently
inhibited the proliferation of Jurkat cells in a dose-dependent
manner (Figure 7a). Concentrations of Hb-cGT as low as 0.1 mg/
mL induced inhibition of T-cell proliferation. Comparison of the
inhibitory potential of supernatants of wild-type and Dggt strains
confirmed the results obtained with the recombinant proteins. The
supernatants of H. bilis wild type reduced T-cell proliferation up to
60%, while the supernatant of Dggt strain had no significant
inhibitory activity. When Jurkat cells were infected with acivicin
pre-treated supernatant of H. bilis wild type, no significant
reduction in proliferation of T-cells was observed, indicating that
only Hb-cGT is responsible for the inhibition of T-cell
proliferation in our system (Figure 7b).
Moreover, both recombinant Hb-cGT and Hp-cGT showed
inhibitory effect on AGS cell proliferation in a dose-dependent
manner as well, although the minimum concentration of protein
required was 25 time higher (2.5 mg/mL) compared to that able to
inhibit the proliferation of human T-cells (Figure 8). No
statistically significant differences were observed between the two
proteins.
Apoptosis in AGS cell line
The ability of recombinant Hp-cGT and Hb-cGT to induce
apoptosis in AGS cells was evaluated using AnnexinV-Propidium
Iodide double staining and FACS analysis. After 24 h of
incubation, concentrations of up to 5 mg/mL of both recombinant
proteins did not induce apoptosis in AGS cells (Figure S4). The
average of percentage of apoptosis observed after treatment with
Hp-cGT and Hb-cGT was 6.961.2% and 6.860.9%, respec-
tively. Those values were not statistically different from the
percentage of apoptosis measured in the untreated cell (7.361.9).
Discussion
Two Helicobacter cGT genes, identified in the shotgun genome
sequence of the human strain H. bilis ATCC 43879 on the basis of
sequence homology, were subjected to functional analysis to
Figure 5. Western Blot on whole H. bilis lysate using specific
antisera against Bgh1 and Bgh2. Western blot of whole H. bilis
lysate using antisera against (A) Bgh1 and (B) Bgh2.
doi:10.1371/journal.pone.0030543.g005
Figure 6. Comparison of the kinetic constants for Helicobacter
bilis cGT (Hb-cGT) at different pH. Error bars in the graphs were
calculated as SEM. The analysis was performed using Prism4 v4.03
(GraphPad Software, San Diego, CA USA). At indicated pH values, kinetic
constants (kcat in black and KM in grey) for the hydrolysis of L-c-
glutamyl-p-nitroanilide (gGpNA) were determined.
doi:10.1371/journal.pone.0030543.g006
Table 2. Comparison of the kinetic constants for Helicobacter
bilis cGT (Hb-cGT) and Helicobacter pylori cGT (Hp-cGT).
kcat [10
2 min21] KM
gGpNA [mM]
Hp-cGT 17.760.5 9.861.5
Hb-cGT 1.1260.03 7.761.2
doi:10.1371/journal.pone.0030543.t002
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confirm their annotations. Although the two genes bgh1 and bgh2
(H. bilis ggt homologue 1 and 2) showed significant homology and
both are classified as T03.01 peptidases in MEROPS, the
evaluation of conserved amino acid residues indicated a marked
difference between these two paralogues, especially in the
substrate-binding pocket. In fact, all critical functional residues
are present in Bgh2, as well as in all the other Helicobacter cGTs,
but not in Bgh1. The amino acid substitutions observed in Bgh1
could potentially affect the enzyme maturation, catalytic activity
and substrate specificity, suggesting different biochemical proper-
ties. Moreover, the absence of a signal peptide in Bgh1, in contrast
to observations for Bgh2 and for the other Helicobacter cGTs,
suggests a different sub-cellular localization of this protein.
We first evaluated the phylogeny of Helicobacter cGTs in relation
with T03 proteases of other bacterial species. The Minimum
Evolution tree clearly showed that both H. bilis T03.01 peptidase
paralogues were phylogenetically associated with other e-proteo-
bacteria cGTs. Nevertheless, Bgh1 formed an independent
branch, indicating a different evolution. Moreover, among
Helicobacter species, only H. trogontum showed two distinct cGT
paralogues, as observed in H. bilis. In addition, the data suggested
that both genes are not restricted to H. bilis ATCC 43879, but are
common features among H. bilis genomospecies and universally
shared by all members of the taxon.
A more detailed phylogenetic analysis further revealed that the
two subunits of cGTs have followed different evolutionary paths.
The tree based on the C-terminal part resembled the topology of
the tree of 16S rRNA and other housekeeping genes and includes
H. bilis in the same branch as other enterohepatic Helicobacter spp.
[38]. On the contrary the phylogenetic analysis of the N-terminal
part separates the cGTs of H. bilis and related species (H. aurati, H.
muridarum and H. trogontum) from others enterohepatic Helicobacter
species. On the basis of our phylogenetic analysis we can
hypothesise that differing phylogeny of the subunits reflects a
possible divergence of substrate specificity between the cGTs of H.
bilis and related species and the other Helicobacter or Campylobacter
cGTs. More studies are needed to verify this hypothesis.
In the trees based on the sequences of both subunits, the
position of the clade including the orthologues of bgh1 indicated
that the paralogues potentially evolved by gene duplication from a
common ancestral sequence probably before the speciation event
of H. bilis and related species. The hypothesis of gene duplication is
well supported also by the low Ka:Ks ratio between the two
paralogues (0,175), indicating that the two genes are under strong
purifying selection [42].
Both sequence and phylogenetic analyses reveal clear differ-
ences between the two H. bilis T03.01 peptidases paralogues. To
compare their biochemical properties, both genes were overex-
pressed in E. coli and the recombinant proteins were purified by
affinity chromatography. The overexpression of Bgh1 resulted in
formation of inclusion bodies due to the accumulation of an
insoluble protein of ,70 KDa. After solubilisation and refolding,
recombinant Bgh1 showed no significant maturation into two
subunits and, subsequently, no cGT activity. In contrast,
recombinant Bgh2 was expressed in soluble form as a pro-enzyme
of ,60 KDa, which undergoes autocatalytic processing to
generate two subunits of ,40 and ,20 KDa and showed cGT
activity. No clear molecular evidence explains the absence of an
autocatalytic process for Bgh1 since all of the amino acid residues
critical for Hp-cGT [2,43] and Ec-cGT [44,45] autoprocessing
Figure 7. Inhibitory effect on T-cell proliferation (Jurkats) by Helicobacter bilis cGT (Hb-cGT). Error bars in the graphs were calculated as
SEM. The analysis was performed using Prism4 v4.03 (GraphPad Software). Different letters on the bars indicate significant differences at P,0.05. (A)
Inhibitory effect with various amounts of recombinant Hb-cGT (Bgh2) protein; statistical analysis was performed using one-way ANOVA, followed by
the Bonferroni test. (B) Inhibitory effect of the culture supernatant of H. bilis wild-type CCUG 23435 (WT) and H. bilis Dggt MR9 (Dggt) with or without
pre-treatment with Acivicin (Sigma-Aldrich); statistical analysis was performed using unpaired t-test.
doi:10.1371/journal.pone.0030543.g007
Figure 8. Inhibitory effect on AGS proliferation by Helicobacter
bilis cGT (Hb-cGT). Error bars in the graphs were calculated as SEM.
The analysis was performed using Prism4 v4.03 (GraphPad Software).
Statistical analysis was performed using one-way ANOVA, followed by
the Bonferroni test. Different letters on the bars indicate significant
differences at P,0.05.
doi:10.1371/journal.pone.0030543.g008
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are also conserved in Bgh1. We, therefore, cannot exclude that the
absence of maturation could be due to misfolding in vitro.
However, the CD spectrum of purified Bgh1 showed that the
protein has a defined set of secondary structures indicating a non-
random folding of the recombinant protein. Moreover, Bgh1 was
unable to restore cGT activity after complementation of E. coli
Dggt mutant. Furthermore, the H. bilis strain in which bgh2 was
disrupted but still able to transcribe bgh1 resulted in deficient cGT
activity. This data clearly indicate bgh1 does not encode a
functional H. bilis cGT. As reported previously, the single amino
acid substitution D433N converts Ec-cGT to a class IV
cephalosporin acylase [46]. Since in Bgh1 the same substitution
is present, we decided to check the potential cephalosporin acylase
activity of H. bilis CCUG 23435, which expresses both cGT
paralogues, as previously described for E. coli [46]. H. bilis did not
show any cephalosporin acylase activity (data not shown),
indicating that glutaryl-7-aminocephalosporanic acid is unlikely
to be a substrate for Bgh1. To elucidate whether the lack of
enzyme activity of Bgh1 is caused by the absence of autocatalytic
maturation, western blot analysis on H. bilis whole lysate using
specific antisera for both cGT paralogues were performed. The
results showed that H. bilis expresses Bgh1 which does not undergo
autocatalytic processing, confirming the results obtained with the
recombinant protein. However, further studies are needed to
determinate potential substrates for Bgh1 and to investigate its role
in the metabolism of H. bilis.
Analysis of the recombinant protein, western blot on H. bilis
whole lysate, complementation of E. coli Dggt and deletion of the
gene in H. bilis CCUG 23435 clearly showed that only bgh2
encodes the functional H. bilis cGT. Hb-cGT exhibited similar
affinity to the substrate analogue gGpNA at pH 8.0 compared
with that of Hp-cGT; however, it was significantly less proficient,
having more than 10-fold less kcat. Moreover, in contrast to
observations for Hp-cGT [30], the affinity of Hb-cGT to gGpNA
varied in relation to the pH, being stronger at acidic and alkaline
conditions and decreasing significantly at pH 6.0 and 7.0. In
addition, Hb-cGT showed the highest activity at pH 6.0, which is
lower compared to previous reports for H. pylori and other
bacterial cGTs [30]. The results of the competition assay
suggested that Hb-cGT and Hp-cGT have similar substrate
specificity, utilizing not only the substrate analogue gGpNA but
also L-glutamine. Nevertheless, Hb-cGT differs from Hp-cGT in
its inability to bind glutathione as substrate. Therefore, we can
speculate that H. bilis cGT lost its ability to interfere the host redox
system. However, the enzyme enables the bacterial cells to use
extracellular glutamine as the source of glutamate. This hypothesis
is supported by the presence in the H. bilis genome of a putative
glutamate transporter gene (HRAG_00091; gltS) showing ,60%
of amino acid identity with H. pylori GltS homologue [47].
Glutamate transporters gltS as well as ggt genes are missing in the
EHS H. hepaticus genomes [47]. Both H. hepaticus and H. bilis are
urease-positive Helicobacter spp., commensal bacterial species and/
or opportunistic pathogens of mice, sharing the same niches in the
lower gastrointestinal tract and causing similar diseases [48].
However, H. bilis, but not H. hepaticus, was also isolated from the
stomach of different hosts [19]. Therefore, the expression of cGT
activity by Helicobacter spp. does not appear to be essential for
colonization of the lower gastrointestinal tract of mice, but it could
provide metabolic advantages in colonization capability of other
tissues or in the adaptation of different hosts.
Although the importance of cGT for physiology and pathobi-
ology of mammalian tissues has been known for many years, its
function in prokaryotic metabolism and its role in interaction with
the host have been studied for only a few bacterial species
[6,9,10,12,47,49–51]. Recently it has been showed that cGT has
an important role in the interaction between H. pylori and the host
by inhibiting T-cell proliferation [9], inducing apoptosis in gastric
cells [10] and contributing to H. pylori–mediated H2O2 generation
[8]. Here, we showed that H. bilis cGT inhibited T-cell
proliferation similar to what was observed for H. pylori [9,10];
the inhibitory effect of T-cell proliferation was completely
abolished in the cGT-deficient mutants of H. bilis. Our data
demonstrate that this activity is not limited to H. pylori but is
conserved among the genus, confirming the potential immune
suppressive role of secreted Helicobacter cGTs. The conserved
function of this enzyme among Helicobacter spp. with different
niches and host specificity opens a new scenario on the role of
cGT in the pathogenesis of Helicobacter associated diseases.
We detected AGS cell proliferation inhibition after treatment
with both recombinant cGTs, as observed for T-cells, but only
when a high concentration was used (2.5 mg/mL). However, in
contrast to what was previously described [10], we showed that the
suppressive influence of both Hb-cGT and Hp-cGT on AGS cells
was mediated by an apoptosis-independent mechanism. The
discrepancy between our results and those of Shibayama and
colleagues [10] could attribute to different methodologies applied,
in particular to the use of serum starvation by these authors. An
increase of apoptosis was verified in AGS cells treated with both
Hp-cGT and Hb-cGT under the same conditions used by these
authors (data not shown), apparently confirming the apoptosis
inducing potential of these enzymes. However, if this phenomenon
is only detectable upon stress conditions (i.e. serum starvation), we
cannot exclude that the observed apoptosis is a consequence of a
nonspecific activity of cGT. Further studies are needed to establish
the real role of cGT in the apoptosis of epithelial cells.
Methods
Bacterial strains, cell line, culture condition and DNA
extraction
The bacterial strains and plasmids used in this study are listed in
Table 3 and 4. All Helicobacter strains were routinely grown on HP
medium (LabM Limited, Lancashire, UK) containing 5% bovine
blood at 37uC in a microaerobic atmosphere (10% CO2; 5% O2)
(Thermo Forma, Series II Water Jacketed Incubator; Thermo
Fisher Scientific, Waltham, MA USA). E. coli strains were
cultivated on Luria-Bertani (LB) agar or broth supplemented with
100 mg/L of ampicillin, 15 mg/L of kanamycin or 20 mg/L of
chloramphenicol when needed. Jurkat T-cells (DSMZ, ACC 282,
Deutsche Sammlung von Mikroorganismen und Zellkulturen
GmbH, Braunschweig, Germany) were cultured in RPMI 1640
(Invitrogen Corporation, Carlsbad, CA, USA) with 10% of foetal
bovine serum (FBS; Gibco, Invitrogen). AGS cells (CLS, 300408;
Cell Lines Service, Eppelheim, Germany) were grown in
Dulbecco’s Modified Eagle’s growth medium (DMEM high
glucose, 11971, Invitrogen) supplemented with 10% FBS and
200 U/mL of penicillin and 0.2 mg/mL of streptomycin (Pen
Strep, Gibco, Invitrogen). Cell lines were incubated at 37uC with
5% CO2. Bacterial DNA extraction was performed as described
earlier [19].
PCR, cloning and sequencing
Consensus DEgenerate Hybrid Oligonucleotide Primers [iCO-
DEHOP [52]] were designed on the basis of highly conserved
amino acid sequences of available Helicobacter and C. jejuni cGTs.
Standard PCR was done in a 50 mL reaction mixture containing
50 ng of DNA template, 25 pmol of each primer and 1.25 U of
DyNAzymeTM (Finnzymes Oy, Espoo, Finland). The 59 consensus
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Table 3. Helicobacter species used in this study.
Species Strain designation and genotype Hosts Reference
[ggt locus tag or accession number and/or bgh1 homologue accession
number]
Gastric Helicobacter spp.
H. acinonychis Sheeba [ggt, Hac_0598] Cheetah; Big Felines [60]
H. bizzozeronii CIII-1 [ggt, HBZC1_08080] Dog; Human [61]
H. felis ATCC 49179 [ggt, Hfelis_06880] Cat [62]
H. mustelae 12198 [ggt, HMU08020] Ferret [63]
H. pylori 26695 [ggt, HP1118] Human [64]
H. salomonis O6A [ggt, EMBL FR821684] Dog [38]
H. suis HS1 [ggt, HSUHS1_0265] Pig [65]
Enterohepatic Helicobacter spp.
H. aurati ATCC BAA-1T [ggt EMBL FR821682] Hamster [38]
H. bilis CCUG 23435 ( =ATCC 43879)[ggt, HRAG_01828; bgh1, HRAG_01341] Mouse; Human; Dog; Cat;
Pig; Sheep
[19]
MR9 ( = CCUG 23435 Dbgh2)
ATCC 51630T [bgh1 homolog EMBL FR821680]
ATCC 49314
ATCC 49320
KO220 [bgh1 homologue EMBL FR821686]
KO214 [bgh1 homologue EMBL FR821687]
KO794 [bgh1 homologue EMBL FR821688]
FL56 [ggt EMBL FR821679] [bgh1 homologue EMBL FR821676]
H. canis NCTC 12739T [ggt EMBL FR821681] Dog; Cat; Human [66]
H. muridarum CCUG 29262T ( = ATCC 49282T) [ggt EMBL FR821683] Mouse [38]
H. trogontum ATCC 700114T [ggt EMBL FR821678] [bgh1 homologue EMBL FR821677] Rat; Mouse; Pig [38]
doi:10.1371/journal.pone.0030543.t003
Table 4. E. coli strains and plasmids used in this study.
Strains or plasmids Relevant characteristics or genotype Reference
Escherichia coli strains
DH5a F2 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG W80dlacZDM15 D(lacZYA-argF)U169,
hsdR17(rK
2 mK
+), l–
[67]
BL21 Rosetta 2 F2 ompT hsdSB(rB
2 mB
2) gal dcm (DE3) pLysSRARE2 (CamR) Novagen
JM109 endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ D(lac-proAB) e14- [F9 traD36 proAB+ lacIq lacZDM15]
hsdR17(rK
2mK
+)
Promega
CY128 DH5a but Dggt DampC [41]
Plasmids
pGEMH-T Promega
pet28b(+) Novagen
pBAD24 pMB1/M13 replicon, Ap+, AraC+, terminator (rrnB), promoter ParaBAD [57]
pUC119 pMB1/M13 replicon, Ap+, lacZa, [68]
pUOA14 pMB1/M13 replicon, pIP1445 replicon, lacZ9, Cm+, Ap+, Km+ [58]
pMRg1 pet28b(+), His6-Bgp1+ this study
pMRg2 pet28b(+), His6-Bgp2+ this study
pMRg3 pBAD24, Bgp1+ this study
pMRg5 pBAD24, Bgp2+ this study
pMRg9 pUC119, bgp2::cam+ this study
doi:10.1371/journal.pone.0030543.t004
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clamp region contains the sequencing primers used for direct
sequencing of the PCR products. If secondary peaks or multiple
sequences were present, the PCR products were inserted into
pGEMH-T and sequenced on both strands using M13 primers.
The area corresponding to nucleotides 702–1569 (amino acids
234–523) of bgh1 was used to design specific primers for RFLP-
PCR protocol. The PCR was done in a 50 mL reaction mixture, as
described above, and then the products were digested by BclI
(NEB, New England Biolabs, Ipswich, MA, USA). BclI specifically
cuts the PCR fragment in two pieces of 606 and 260 bp. EMBL
accession numbers are listed in Table 3. All oligonucleotides used
in this study are listed in Table 1.
Phylogenetic analysis
Phylogenetic analyses of cGT amino acid sequences were
conducted in MEGA4 [53] using the Minimum Evolution (ME)
method. The amino acid sequences were aligned using MAFFT
[54]. The evolutionary distances were computed using the Dayhoff
matrix-based method, and the ME tree was searched using the
Close-Neighbor-Interchange (CNI) algorithm (level 1). All posi-
tions containing alignment gaps and missing data were eliminated
in pairwise sequence comparisons [53]. A multi-alignment of ggt
sequences of Helicobacter spp and C. jejuni was built in MEGA4 on
the basis of the amino acid sequence alignment. Maximum
likelihood (ML) trees were constructed using PHYML [55] with a
nucleotide evolution model selected by FindModel (http://www.
hiv.lanl.gov/). Trees were visualized by iTOL [56]. Non-
synonymous/synonymous substitution (Ka:Ks) was evaluated by
sliding window analysis (window size of 50 bp) using SWAKK
[37].
Expression of Bgh1 and Bgh2 and purification of
recombinant proteins
Primers pairs were designed to amplify complete sequences of
bgh1 and bgh2 genes using PhusionH High-Fidelity DNA
Polymerase (Finnzymes). Bgh1 and Bgh2 were expressed as
66His-tagged proteins by inserting the genes respectively in NdeI
and HindIII or NheI and HindIII restriction sites of pet28b+ vector
(NovagenH, Merck KGaA, Darmstadt, Germany). The 66His-tag
was fused in the N-terminal part of the proteins. The resulting
expression constructs pMRg1 and pMRg2 were sequenced and
confirmed to be identical to bgh1 and bgh2, respectively. Both
expression constructs were used to transform E. coli Rosetta 2
(NovagenH). Expression of recombinant protein was induced with
0.5 mM IPTG for 4 h at 27uC. After centrifugation, pellets were
solubilized in ice-cold binding buffer (50 mM Tris-HCl, 500 mM
NaCl, 10 mM imidazole, pH 7.4) containing protease inhibitors
and then lysed by subsequent sonication (5 times for 30 s) on ice.
The supernatant was loaded on the HisTrapTM column (GE
Healthcare Biosciences, Pittsburgh, PA, USA) at 1 mL/min at
4uC, and bound protein was eluted with an imidazole-gradient (0–
100 mM imidazole) using the elution buffer (50 mM Tris-HCl,
500 mM NaCl, 1000 mM imidazole, pH 7.4). Eluates were
collected and then tested for purity by SDS-PAGE. Since
purification of a soluble form of Bgh1 was not possible, the
sonicated cells of E. coli (4 times for 1 min) were homogenized,
solubilized in 6 M Gua-HCl, 1 mM DTT, 10% Glucose pH 8.5
and stirred for 1 h at 4uC. Following centrifugation, the
supernatant containing the unfolded protein was loaded on a
HisTrapHPTM column (GE Healthcare) at 4uC. The bound
protein was refolded with a gradient of 100 mM HEPES, 5%
Glucose, 250 mM NaCl, 10 mM MgCl2, 1 mM DTT pH 8.5 (0–
100% of HEPES buffer). After the refolding, the column was
washed extensively with 5 column volumes of HEPES buffer, and
bound protein was eluted with an imidazole-gradient (0–
1000 mM) using HEPES buffer with 1000 mM imidazole. Eluate
was collected and then tested for purity by SDS-PAGE. For
further purification, fractions with the recombinant proteins from
Ni-Sepharose affinity chromatography were pooled, dialysed
overnight against 100 nM HEPES, 140 mM NaCl, 2.5% Sucrose
pH 7.0, at 4uC and processed to the second and final purification
step. The dialysed samples were loaded on a SuperdexTM75
column (GE Healthcare) and equilibrated with 100 nM HEPES,
140 mM NaCl, 2.5% Sucrose pH 7.0. All fractions collected were
analysed by SDS-PAGE for the presence of recombinant proteins.
Fractions containing the protein were pooled, aliquoted and stored
at 280uC until further use.
Circular Dichroism (CD) spectrum of the recombinant
Bgh1
To estimate the secondary structure of Bgh1 a CD spectrum of
the recombinant protein was calculated. The measurements were
performed on a JASCO J-810 spectropolarimeter equipped (Jasco
Labor- und-Datentechnik GmbH, Gross-Umstadt, Germany)
using a 0.2-mm-pathlength quartz-glass cuvette 1-mm. CD spectra
were recorded with 50 ml of the sample at final concentration of
15 mM in 20 mM KH2PO4 pH 7.5, 50 mM K2SO4. All CD
measurements were corrected by subtracting the buffer spectrum.
The following parameters were used: data pitch, 0.1 nm;
continuous scanning mode at 100 nm/min; response, 4 sec; band
width, 1 nm; accumulation, 16. Smoothing was made by the
method Means-Movement. Data were collected using Spectra
manager v1.54.03 (Jasco).
Immunization of mice and Western-Blot on whole H. bilis
lysate
Balb/c mice (3 mice per group) were immunized i.p. with 30 mg
of antigen and 10 mg Cholera toxin (CT) (Sigma-Aldrich) as
adjuvant at days 0, 7 and 14 (control group with CT only). Sera
were taken 21 days after the last immunization and stored at
220uC. Animal experiments were performed according to the
guidelines of the Bavarian Ministry of Animal Wealth Fare. For
evaluation of Bgh-specificity, ELISA plates were coated with 2 mg/
mL recombinant Bgh1 and Bgh2 proteins in PBS pH 7.4
overnight at 4uC. After washing (460.01% Tween-20 in PBS)
and blocking (1% BSA in PBS), different dilutions of sera (in
blocking buffer) were incubated for 1 h at 37uC. HRP-conjugated
anti-mouse IgG antibody (1:3000) (Promega Corporation, Fitch-
burg, WI, USA) was incubated (1 h at 37uC) and detected with
ELISA Opt EIATM (BD, Becton, Dickinson and Co., NJ, USA)
according to the manufacturer’s instructions.
For the western blot, H. bilis overnight culture was resuspended
in 1 mL BHI (BD). Following lysis (sonication 4630 sec), the
protein-concentration in cleared lysates was determined by BCA-
Assay and adjusted to 1 mg/mL. Per lane 5 mg of total protein
were loaded. After blocking with 5% BSA in Tris-buffered saline
(TBS), the Whatman ProtranH Nitrocellulose membranes (GE
Healthcare) were incubated for 1 h at RT with the sera of the
immunized mice (1:800 diluted in TBS). Following washing, HRP-
conjugated secondary anti-mouse IgG antibody (Promega) (diluted
1:3000 in TBS) was added and detected by the acridan-based
ECL-system (Thermo Fisher Scientific).
Complementation of E. coli Dggt
bgh1 and bgh2 were amplified as described above and were
inserted between KpnI and HindIII restriction sites of pBAD24
expression vector [57], resulting in pMRg3 and pMRg5,
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respectively. Both expression constructs were used to transform E.
coli CY128 Dggt. The recombinant strains were grown in LB
medium with ampicillin at 37uC to OD600<0.4, and the
expression of the corresponding gene was induced with 0.2% L-
arabinose for 4 h at 25uC. The basal expression of pMRg3 and
pMRg5 vectors was inhibited by using 0.2% of glucose instead of
L-arabinose. Expressions were verified by SDS-PAGE electropho-
resis and Coomassie Blue stain. A total of 109 cells were harvested
by centrifugation and stored at 270uC before the cGT assay.
Construction of H. bilis isogenic mutant
Chromosomal inactivation of bgh2 was performed in H. bilis
CCUG 23435. Deletion was introduced by allelic exchange using
vector pUC119 in which ,1100 bp of the 59 –end and ,500 bp
of the 39 –end of the target gene and the chloramphenicol
resistance gene from pUOA14 [58] were cloned. The resultant
plasmid, pMRg9, was constructed and amplified in E. coli DH5a
and used as a suicide plasmid in H. bilis CCUG 23435. H. bilis
mutant was obtained by electroporation as described for H.
hepaticus [59]. The mutant strain, H. bilis MR9 (bgh2::cam), was
selected on an HP medium containing 5% bovine blood
supplemented with chloramphenicol (20 mg/mL). The site of
recombination was verified by PCR.
RNA extraction and RT-PCR
To analyse the expression of both bgh1 and bgh2 during growth,
H. bilis wild-type CCUG 23435 was cultivated in Brain Heart
Infusion (BHI; BD, NJ USA) containing 20% FBS and Vitox
supplement (Oxoid Ltd., Cambridge, UK) at 37uC microaerobi-
cally by continuous shaking at 150 rpm. OD600 was measured at
8, 16 and 24 h and the same amount of cells was treated with
RNAprotect Bacteria Reagent (Qiagen GmbH, Hamburg Ger-
many). RNA was extracted using RNeasy Mini Kit (Qiagen) and
treated with TURBO DNaseTM (Applied Biosystems/Ambion,
Austin, TX, USA). Moreover, H. bilis CCUG 23435 and the
mutant MR9 were cultivated in YT62 medium (16 g/L
Tryptone, 10 g/L Yeast Extract, 5 g/L NaCl) containing 10%
FBS at 37uC in a microaerobic atmosphere. After 24 h RNA was
extracted as described above. cDNAs were synthesized from 1 mg
of total RNA using SuperScriptH III Reverse Transcriptase
(Invitrogen) using random hexamers (Finnzymes). RT-PCR
reactions were carried out in a total volume of 50 mL as described
above, using 1 mL of cDNA and 1 mL of RNA as negative control
and 20 pmol of specific primers for bgh1 and bgh2. Thermocycling
conditions were 94uC for 2 min followed 40 cycles of 94uC for
45 s, 58uC for 45 s and 72uC for 1 min. The PCR products were
sequenced using the same primers.
T-cell and AGS proliferation assay
For measurement of the effect of H. bilis cGT on T-cell
proliferation, Jurkat cells were seeded at 56103 per well in a
complete culture medium in 96-well microtiter plates and a
variable amount of protein (0.001 to 10 mg/mL) or sterile-filtrated
culture supernatant (1 mg/mL total protein) was added in a total
volume of 100 ml. As a control for the inhibition of T-cell
proliferation, the recombinant cGT from H. pylori 26695 (HP-
cGT) was used. The HP-cGT was produced as previously
described [9]. Additionally, supernatant were preincubated with
50 mM Acivicin for 30 min at 37uC to inactivate the cGT. Cells
were incubated at 37uC for 48 h and analysed for proliferation as
described previously [9]. Results are expressed as the mean6SEM
from three experiments.
For the measurement of the effect of recombinant H. bilis and
H. pylori cGT on proliferation of AGS cells, 56103 cells per well
were seeded in culture medium in a 96-well plate and treated with
0.5–5 mg/mL of protein in a total volume of 100 ml. Cells were
incubated at 37uC for 48 h and analysed for proliferation as
described above.
Apoptosis in AGS cells
Apoptosis in gastric epithelial cells was determined by
Fluorescence-activated cell sorting (FACS). AGS cells were seeded
in a 6-well plate till they reached a confluence of 60–70%, and
treated for 24 hours with 0.5–5 mg/mL of purified recombinant
cGT proteins from H. pylori and H. bilis in DMEM with 10% of
FBS. Untreated cells were used as a negative control and cells
treated with 10 mM of Staurosporine (LC laboratories, Woburn,
MA, USA) as a positive control for apoptosis. Cells were harvested
with 0.25% Trypsin-EDTA (Invitrogen) and 26105 cells were
washed once with PBS. The pellets were resuspended in 10 mg/
mL of AnnexinV-FITC antibody (BD, Becton, Dickinson and Co.,
NJ USA) in FACS buffer and incubated for 20 minutes in dark at
room temperature. Cell suspensions were then diluted with FACS
binding buffer and 10 ml of 50 mg/mL of Propidium Iodide
(Sigma-Aldrich, Inc, St Louis, MO, USA) was added before
acquiring samples. Cell debris was excluded by scatter gating
(forward vs. side scatter). Approximately 50,000 events were
collected per sample using CyAn ADP FACS cytometer (Beckman
Coulter, Inc., CA, USA) and data was analysed with FloJo
software (Tree Star, Inc, Oregon, USA). The percentage of
apoptotic cells is expressed as the double positive cell population
(AnnexinV+PI) and pre-apoptotic cells stained only for AnnexinV.
cGT enzymatic and competition assays
For determination of cGT activity, ,109 bacteria were
suspended in 400 mL of reaction buffer containing 1 mM of L-c-
glutamyl-p-nitroanilide (gGpNA) as described previously [6].
Additionally, culture supernatants, containing 50 mg/mL protein
were analysed by diluting 50 mL of supernatant in 150 mL of
reaction buffer. The kinetic parameters for the enzymatic reaction
of the recombinant proteins were measured by following the
cleavage of gGpNA. To determine the exchange rate of the
substrate to 4-p-nitroaniline, the reaction was monitored at
405 nm and calculated by using the reported extinction coefficient
of 8800 M/cm. Enzymatic activity was measured in 0.1 M Tris
HCl with a pH range from 5.0 to 9.0, 20 mM glycyl-glycine and
gGpNA at a concentration range from 1 mM to 2.5 mM. The
experiments were carried out at 37uC for 30 min using a Mithras
LB940 Well-Reader. The initial rates were determined at each
gGpNA concentration and entered in the Michaelis-Menten
equation. To investigate the affinity of the postulated cGT-
substrates (i.e. L-Glutamine, D-Glutamine, L-Glutamic acid and
Glutathione), we made a competition experiment in which the
hydrolysis and transpeptidation of gGpNA was analyzed by
measuring the absorption at 405 nm in the presence of cGT-
substrates. For this assay we used 250 ng of the Hb-cGT or Hp-
cGT per reaction with 100 mM gGpNA, 10 mM GlyGly and the
substrates in a concentration-range between 0–5 mM in 100 mM
Tris/HCl pH 8.0. The measurement was performed for 15 min at
37uC in a total volume of 200 ml.
Supporting Information
Figure S1 CD spectrum and photomultiplier voltage for
recombinant Bgh1. (A) CD spectrum for recombinant Bgh1
(black line), the predicted spectrum for Bgh1 obtained by K2D3
(red line) and lysozyme (blue line). The spectrum for lysozyme was
taken from the Protein Circular Dichroism Data Bank (http://
Helicobacter c-Glutamyltranspeptidases Comparison
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pcddb.cryst.bbk.ac.uk/). (B) Photomultiplier voltage of the spec-
trum for recombinant Bgh1.
(TIF)
Figure S2 Rate of gGpNA turnover of culture superna-
tant (50 mg/mL total protein) of Helicobacter bilis wild-
type CCUG 23435 (WT) and H. bilis DggtMR9 (Dggt). The
white bars show the results for untreated culture supernatants,
while the black bars show the results after treatment of culture
supernatants with 50 mM of Acivicin.
(TIF)
Figure S3 cGT-activity competition with glutathione,
L-/D-Glutamine and L-Glutamic Acid. Error bars in the
graphs were calculated as SEM. The analysis was performed using
Prism4 v4.03 (GraphPad Software). Inhibitory effect with various
amounts of substrate analogues on (A) Helicobacter bilis cGT (Hb-
cGT) and (B) Helicobacter pylori cGT (Hp-cGT).
(TIF)
Figure S4 Apoptosis analysis of AGS cells after 24 hour
treatment with cGT recombinant proteins. AnnexinV and
PI staining of AGS cells analysed by Flow cytometer treated with
0.5, 0.25 and 5 mg/mL of recombinant proteins from Helicobacter
bilis (Hb-cGT), and Helicobacter pylori cGT (Hp-cGT), compared to
untreated cells and cells treated with staurosporin.
(TIF)
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